Introduction
============

Periodontitis, a polymicrobial disease that causes destruction of the structures that anchor the tooth to the jawbone, is the sixth most prevalent disease in the world, affecting over 750 million people ([@bib22]; [@bib37]). Smoking and diabetes are the only known risk factors for this disease, increasing the extent and severity of periodontitis by 3--10-fold and hastening periodontal destruction exponentially ([@bib65]; [@bib7]; [@bib67]). Periodontitis has been called the sixth complication of diabetes ([@bib47]), with one-third of diabetics suffering from severe periodontitis ([@bib10]). Nearly 42% of periodontitis cases can be attributed to smoking ([@bib67]), and critically, 24% of diabetics smoke ([@bib25]), thus creating three high-risk groups for periodontal diseases: smokers, diabetics and diabetic smokers. With nearly 30 million Americans suffering from adult-onset diabetes ([@bib10]) and over 1 billion smokers worldwide ([@bib56]), preventing periodontitis in these high-risk populations will be a highly cost effective healthcare strategy.

Although it is established that dysbiosis of the indigenous periodontal microbiome is the primary etiological trigger for periodontitis ([@bib31]), the events that lead to this dysbiosis are not well understood. A central characteristic of any ecosystem is its response to environmental perturbations, which plays a critical role in altering both community structure and membership. Smoking and diabetes are two environmental presses that affect the subgingival environment in unique ways. While smoking leads to peripheral vasoconstriction ([@bib14]), decreased vascular permeability and hyperemia ([@bib50]), decreased flow of gingival crevicular fluid ([@bib29]) and lower oxygen tension ([@bib34]), hyperglycemia affects this environment by increasing glucose levels ([@bib69]), vascular permeability, and levels of matrix metallo-proteinases, cytokines and adhesion molecules (reviewed by [@bib66]). Thus, the subgingival milieu in smokers is anaerobic, acidic, reducing, nutritionally deprived and immune-impaired. In diabetics, this environment is glucose-rich, pro-oxidant, protein-rich and anaerobic.

The effects of smoking on the oral microbiome have been extensively studied in recent years and several investigations have established that the oral microbiome shifts in response to this environmental press ([@bib26]; [@bib19]; [@bib63]; [@bib39]; [@bib68]). Smoking creates pathogen-rich, commensal-poor microbial ecosystems even in clinically healthy individuals that closely resemble disease-associated communities ([@bib38]; [@bib49]). Although it is known that uncontrolled hyperglycemia similarly increases the risk for periodontitis, very few studies have examined the effects of diabetes on the subgingival microbiome ([@bib71]; [@bib13]; [@bib42]; [@bib58]; [@bib9]; [@bib72]). Furthermore, there are no studies that examine the effects of intersecting environmental presses on periodontal microbiota.

Hence, the goal of the present investigation was to examine the effects of each environmental press on the structure and membership of the subgingival microbial communities using an open-ended deep sequencing approach. To the best of our knowledge, we present the first available evidence on the combined effects of these two environmental presses on the subgingival microbiome.

Materials and methods
=====================

Ethics statement
----------------

Approval for this study was obtained from the Office of Responsible Research Practices at The Ohio State University and the Ethics Committee of Rajiv Gandhi University and carried out according to the approved guidelines. All participants gave written informed consent prior to enrollment.

Subject selection
-----------------

Subjects with generalized moderate to severe chronic periodontitis (attachment loss ⩾5 mm, probing pocket depths ⩾5 mm, mean gingival index ([@bib46]) \>1 in 30% of more of sites ([@bib3])) were recruited from two centers in India and the United States, and informed consent obtained. A total of 25 subjects were recruited into each of the following groups: normoglycemic nonsmokers, hyperglycemic nonsmokers, normoglycemic smokers and hyperglycemic smokers. Additionally, 75 periodontally healthy individuals were recruited and distributed equally among the three groups: normoglycemic nonsmoker, hyperglycemic nonsmoker and normoglycemic smoker. Periodontal health was defined as attachment loss ⩽1 mm, probing pocket depths ⩽3 mm, mean gingival index \<1. Smokers were defined as⩾10 pack-year histories and currently smoking more than 3 times a week, nonsmokers were defined as those who smoked \<100 cigarettes in their lifetime and were not currently smoking (CDC guidelines). Type 2 diabetes was defined as untreated adult-onset hyperglycemia with a glycated hemoglobin (HbA1c) level of ⩾6.5 and normoglycemia as HbA1c of ⩽6 ([@bib2]). Exclusion criteria included conditions that required the use of prophylactic antibiotics, current or planned pregnancy, HIV infection, long-term (\>3 months) use of medications known to cause gingival changes, (for example, immunosuppressants, phenytoin, calcium channel blockers, aspirin, NSAIDS, bisphosphonates or steroids), antibiotic therapy or oral prophylactic procedures within the last 3 months and less than 20 teeth in the dentition. The groups were frequency matched for age, gender, BMI and extent and severity of periodontal destruction.

Sample collection
-----------------

Samples were collected from both deep and shallow sites of subjects with periodontitis. Prior to sample collection, selected sites were isolated and supragingival plaque was removed. Subgingival plaque was collected and pooled from four non-adjacent proximal sites with probe depths of ⩾6 mm, BOP, and GI \>1 (disease or deep-site samples) by inserting 15 sterile endodontic paper-points (Caulk-Dentsply, Milford, DE, USA). Samples were similarly acquired from four sites with probe depths of ⩽3, no BOP and GI ⩽1 and separately pooled (healthy or shallow-site samples). A total of 15 randomly selected interproximal sites were sampled from periodontally healthy subjects. Samples were placed in 1.5-ml microcentrifuge tubes and frozen at −20 °C until further analysis.

Sequencing and analysis pipeline
--------------------------------

DNA was isolated as previously described ([@bib41]) and multiplexed bacterial tag-encoded FLX 16S pyrosequencing was performed using the Titanium platform (Roche Applied Science, Indianapolis, IN, USA). Two regions of the 16S rRNA genes were sequenced: V1--V3 (spanning *E.coli* 16S gene regions 8--27 and 519--536) and V7--V9 (spanning *E.coli* 16S gene regions 1099--1114 and 1528--1541). The primers used for sequencing have been previously described ([@bib41]). Each primer is capable of detecting a range of genera that the other fails to recover. Together they allow the recovery of a wider range of the microbiome than is possible with a single primer alone. However, some genera are picked up by both primers. Thus, to prevent over counting, the number of sequences assigned to an OTU by both primers was reduced by half. Primer averaging was carried out as previously described ([@bib41]) using the implementation in the PhyloTOAST software suite ([@bib17]). Sequences with an average quality score of 30 over a sliding window of 50 bp and length \>200 bp were assigned a taxonomic identity by alignment to the HOMD database ([@bib12]) using the Blastn algorithm. Analyses were conducted using the QIIME ([@bib8]) and PhyloToAST ([@bib17]) pipelines.

Statistical analysis
--------------------

Principal coordinate analysis (PCoA) of UniFrac distances was used to interrogate the robustness of group-wise clustering and Adonis test was used to estimate statistical significance of group-wise beta-diversity ([@bib51]). Linear discriminant analysis (LDA) was performed using the *MASS* package for R. The input for LDA was a matrix of variance-stabilized (arc-sin square root transformed) relative abundances of species-level OTUs ([@bib64]). MASS:lda provided singular value decomposition (svd) values, which were used to calculate the percent variance explained in each dimension. MANOVA/Wilks lambda was used to test for significance of LDA clustering. Alpha diversity of s-OTUs was estimated using Abundance Coverage Estimator (ACE) Index and the Wilcoxon and Kruskal--Wallis tests were used for significance testing of two and multi-group comparisons respectively. Differential abundance analysis of OTUs was carried out using DESeq2 ([@bib48]) and *P*-values adjusted for multiple testing (FDR\<0.1, FDR-adjusted Wald Test). Results were visualized using PhyloToAST ([@bib17]; PCoA plots, diversity curves), and the Interactive Tree Of Life webserver (phylogenetic tree) ([@bib45]). Species-level co-occurrence networks for each group were created using JMP (SAS Institute Inc., Cary, NC, USA) to calculate pairwise correlations; significant co-occurrences (defined as Spearman's rho \>0.75 and *P*\<0.05 (*t*-test of rho)) were imported into Networkx ([@bib32]) to create the graph structures, and Gephi ([@bib6]) to visualize and label the graphs. A core microbiome was computed for each group as the suite of species identified in ⩾80% of individuals in that group. Robustness of clustering was examined using an algorithm incorporating betweenness centrality, differential abundances, and frequency of occurrence in a group as described before ([@bib59]). Betweenness centrality was calculated using Python package '*Networkx'* and s-OTUs were ranked based on this metric. For each group, significantly different (*P*\<0.05, Tukey-HSD) species were identified using JMP (SAS Institute Inc.) and species that were present in at least 75% of the subjects were identified using QIIME's core_microbiome.py script. Species that demonstrated a high betweenness centrality (top 20% in each network), and were either part of the group's core microbiome or showed significant differences between the groups were identified as network anchors. A relative risk model was used to investigate whether the effects of smoking and diabetes were additive or multiplicative ([@bib33]). Contingency tables were created using smoking and diabetes as conditions and alpha diversity, relative abundances of gram-positive and gram-negative organisms and the number of species in the core microbiome as response variables. Relative risk was calculated for each response variable in diabetics and smokers and summed to compute the expected relative risk when both factors intersect. This was compared to the observed relative risk in diabetic smokers.

Results
=======

[Table 1](#tbl1){ref-type="table"} shows the demographic, clinical and biometric characteristics of the groups. A total of 2.7 million high quality, classifiable sequences from 275 samples were used for analysis. The sequences have been deposited in the Sequence Read Archive of the NCBI (Accession number: SRP090878). These sequences represented 564 species-level operational taxonomic units (s-OTUs) with an average of 168±54 s-OTUs in each sample. The samples did not demonstrate any clustering based on geographic location (India versus United States, data not shown).

Periodontitis is associated with a global dysbiosis of the subgingival microbial ecosystem
------------------------------------------------------------------------------------------

Chronic periodontitis is a site-specific disease, that is, at any point in time certain teeth demonstrate destruction of tooth-supporting structures and inflammation (deep sites) and others are disease-free (shallow sites; [@bib30]). Principal coordinate analysis (PCoA) of unweighted UniFrac distances did not show significant clustering of sites (*P*=0.76) based on this clinical phenotype ([Figures 1a--d](#fig1){ref-type="fig"}). The ACE index was not significantly different between the clinical sites (*P*=0.192, [Figures 1e--h](#fig1){ref-type="fig"}). Thus, in a subject with disease, differences in community structure or membership were not apparent based on severity of periodontal destruction.

Distinct subgingival microbial assemblages are associated with uncontrolled chronic hyperglycemia
-------------------------------------------------------------------------------------------------

75% of the microbiome of type 2 diabetics with periodontitis was composed of gram-positive facultatives and gram-negative anaerobes ([Figure 2d](#fig2){ref-type="fig"}). The community was dominated by species belonging to the genera *Fusobacterium, Parvimonas, Peptostreptococcus, Gemella, Streptococcus, Leptotrichia, Filifactor, Veillonella*, TM7 and *Terrahemophilus.*

When this community was compared to normoglycemic individuals with periodontitis, both PCoA (*P*=0.001, Adonis test of UniFrac distances) and LDA (*P*=0.001, MANOVA Wilks test) revealed a significant clustering of microbiomes based on glycemic status ([Figure 2a](#fig2){ref-type="fig"}). Moreover, within the diabetic group, significant clustering was observed based on HbA1c levels (pre-diabetic (\<6.5%), diabetic (6.5--9.9%), diabetics\>10% ([@bib2]), [Figure 2b](#fig2){ref-type="fig"}). Diabetics exhibited significantly lower species richness (*P*=0.0008, Wilcoxon test [Figure 2c](#fig2){ref-type="fig"}), and lower levels of anaerobes and higher levels of facultatives (both gram-positive and gram-negative) when compared to normoglycemic individuals with periodontitis (*P*\<0.05, Wilcoxon test [Figure 2d](#fig2){ref-type="fig"}), a finding that corroborates earlier research using a similar methodology ([@bib9]; [@bib72]).

A total of 81 species comprised the core microbiome of normoglycemic controls, 46 of these were not identified in hyperglycemic cores ([Figure 3a](#fig3){ref-type="fig"}). Also, only 42 species formed the core microbiome of periodontitis in diabetics and seven of these were not detected in normoglycemics with periodontitis.

Higher levels of species belonging to *Lactobacillus, Corynebacterium, Pseudomonas* and lower levels belonging to *Treponema, Porphyromonas, Prevotella,* and *Parvimonas* were observed in diabetics (*P*\<0.05, FDR-adjusted Wald test, [Figure 4a](#fig4){ref-type="fig"}).

Network analysis revealed significant co-occurrence patterns between the core species ([Figure 5](#fig5){ref-type="fig"}). In the normorglycemic state, co-occurrence was mainly congeneric and sparse, with species belonging to *Streptococcus, Neisseria, Selenomonas* and *Treponema* driving the clusters. On the other hand, diabetics with periodontitis displayed two robust microbial hubs with several inter-generic networks, one that consisted of uncultivated phylotypes belonging to TM7, *Treponema, Microbacterium* and *Sphingomonas* and the other comprising *Fretibacterium* and Peptostreptococcaceae \[XI\] \[G4\] and \[XII\] \[G5\], and *Filifactor alocis*.

To examine the ecological shifts from health to disease in hyperglycemics, the microbiomes of diabetics with and without periodontitis were analyzed and compared to periodontally healthy normoglycemics. PCoA and LDA revealed significant clustering of groups based on both glycemic status and periodontal health (*P*=0.01, [Figure 6a](#fig6){ref-type="fig"}). Periodontally healthy diabetics exhibited significantly lower species richness than both diabetics with periodontitis and periodontally healthy controls (*P*=0.0019, [Figure 6b](#fig6){ref-type="fig"}). Lower levels of gram-positive facultatives and higher levels of gram-positive and gram-negative anaerobes were seen in periodontally healthy hyperglycemics when compared to periodontally healthy normoglycemics ([Figure 6c](#fig6){ref-type="fig"}). When the data were analyzed at the level of the core species, further differences between periodontal health and periodontitis in diabetics could be observed ([Figure 3b](#fig3){ref-type="fig"}). Ten percent (7 out of 71 species) of the overall core microbiome (*Campylobacter gracilis, Corynebacterium matruchotii, Fusobacterium nucleatum, Gemella sanguinis, Granulicatella adiacens, Streptococcus oralis* and *Streptococcus sanguinis)* was shared by all the three groups. Forty-three percent (13 out of 30) of the species identified in periodontally healthy normoglycemics were not detected in periodontally healthy diabetics. In addition, 30 species were identified only in the core microbiome of periodontally healthy diabetics; however, none of these were detectable in diabetics with periodontitis ([Figure 3b](#fig3){ref-type="fig"}). Thus, it appears that a disease-associated community framework (with decreases in relative abundances of health-compatible species, and increases in levels of species belonging to the genera *Porphyromonas, Prevotella, Campylobacter* and *Fusobacterium),* is established in states of periodontal health in diabetics; and during progression to disease, community membership undergoes further shifts.

Distinct patterns of microbial assembly observed in smokers and hyperglycemics
------------------------------------------------------------------------------

PCoA and LDA revealed a significantly distinct clustering of periodontitis-associated microbiomes based on glycemic status and tobacco exposure (*P*=0.001, [Figure 2a](#fig2){ref-type="fig"}). Diabetics and smokers exhibited similar species richness (*P*=0.3130, [Figure 2c](#fig2){ref-type="fig"}). However, diabetics demonstrated lower levels of anaerobes and microaerophiles (belonging to the genera *Parvimonas*, Prevotella, *Tannerella, Lachnoanaerobaculum, Lactobacillus, Fretibacterium, Dialister*, *Eubacterium*, *Fusobacterium*, *Atopobium*, *Alloprevotella* and *Porphyromonas* and higher levels of facultatives (for example, *Hemophilus, Pseudomonas, Neisseria)* when compared to smokers (*P*\<0.05, [Figure 4b](#fig4){ref-type="fig"}). While smokers demonstrated lower levels of facultatives and higher abundances of anaerobes when compared to normoglycemics, diabetics exhibited the exact opposite distributions ([Figure 2d](#fig2){ref-type="fig"}). The core microbiome of periodontitis in smokers was larger than that of diabetics (22% of s-OTUs in smokers and 17% in diabetics, [Figure 3a](#fig3){ref-type="fig"}). Moreover, the core species in smokers accounted for 85% of the overall abundance. By contrast, only 32% of the overall abundance in diabetics was contributed by the core species. Co-occurrence was sparse and congeneric in smokers, and robust inter-generic microbial hubs were seen in diabetics ([Figure 5](#fig5){ref-type="fig"}).

To compare the ecological shift from health to disease between smokers and diabetics, the microbiomes of smokers with and without periodontitis were analyzed and compared to periodontally healthy nonsmokers (controls). In contrast to diabetics, PCoA and LDA revealed distinct clustering of groups (*P*=0.01) based on smoking status but not disease status ([Figure 7a](#fig7){ref-type="fig"}). Smokers with periodontitis exhibited significantly lower species richness than both periodontally healthy smokers and nonsmokers (*P*=0.00003, [Figure 7b](#fig7){ref-type="fig"}). Both periodontally healthy smokers and smokers with periodontitis exhibited significantly lower levels of facultatives and higher levels of anaerobes when compared to periodontally healthy nonsmokers (*P*=0.005, [Figure 7c](#fig7){ref-type="fig"}). Similar to diabetics, periodontally healthy smokers shared only a small fraction (29%) of their core microbiome with healthy nonsmokers ([Figure 3c](#fig3){ref-type="fig"}). However, unlike diabetics, smokers with periodontitis shared 86% of their microbiome with periodontally healthy smokers.

In summary, while certain community trends (low inventory diversity, periodontitis-associated signatures in periodontal health) were similar between smoking and diabetes, these communities demonstrated significant differences based on the environmental perturbation. For instance, the microbial profile was significantly more homogenous among smokers than diabetics, as evidenced by the larger core microbiome and the inclusion of numerically dominant species in the core in the former. Thus, while differences among individuals who smoke were due to species that together accounted for \<15% of the overall abundance (the 'rare biosphere'), in diabetics, numerically dominant species varied significantly among individuals, contributing to significant inter-individual variation or heterogeneity. Smokers demonstrated lower levels of anaerobes and higher levels of aerobes when compared to normoglycemics, on the other hand, diabetics demonstrated the exact opposite trend. Co-occurrence appeared to be driven by interbacterial interactions in smokers, and by the microenvironment in diabetics. Moreover, transition from health to disease was not accompanied by microbial shifts in smokers; in diabetics, transition from health to disease was associated with introduction of new members and loss of others.

A tale of two risks---the combined effect of smoking and diabetes is greater than the sum of the parts
------------------------------------------------------------------------------------------------------

To investigate the combined effects of diabetes and smoking on the subgingival microbiome, we compared the microbial assemblages of uncontrolled hyperglycemics with a 10 pack-year smoking history to normoglycemic smokers and hyperglycemic nonsmokers. All these individuals had periodontitis; unlike the smokers, diabetics and controls, we were unable to identify periodontally healthy diabetic smokers. PCoA as well as LDA revealed a significant clustering of the three groups (*P*=0.001, [Figure 2a](#fig2){ref-type="fig"}). Diabetic-smokers also demonstrated significantly lower alpha diversity (median of 150, *P*=0.0001), a bimodal distribution of the density plot and a significantly greater range in the ACE index when compared to diabetics or smokers ([Figure 2b](#fig2){ref-type="fig"}). Additionally, the relative risk for diabetic smokers to demonstrate an ACE index \<150 was 11, while it was 2.1 for smokers and 4.7 for diabetics. Diabetic-smokers exhibited lower levels of gram-negative anaerobes and higher levels of gram-negative facultatives when compared to both smokers and diabetics (*P*\<0.05, [Figure 2c](#fig2){ref-type="fig"}). The microbiomes of 23 diabetic smokers contained gram-negative facultatives at 10% or more of the total microbiota (and gram-negative anaerobes at 15% or less), while six diabetics and two smokers had the same numbers. These species belonged to *Leptotrichia, Pseudomonas, Acinetobacter, Brevundimonas, Enterobacter, Alloprevotella, Bergeyella, Terrahemophilus* and *Stenotophomonas* (*P*\<0.05, [Figures 4c and d](#fig4){ref-type="fig"}). The core microbiome in diabetic smokers was the smallest (4% of s-OTUs in diabetic smokers when compared to 30% in controls, 23% in smokers, and 18% in diabetics, [Figure 3a](#fig3){ref-type="fig"}). However, microbial species in diabetic smokers demonstrated the most robust co-occurrence patterns, with over 150 s-OTUs contributing to the creation of microbial hubs ([Figure 5d](#fig5){ref-type="fig"}). Taken together, the relative risk of having a lower diversity, higher levels of gram-negative facultatives, lower levels of gram-negative anaerobes and a smaller core are much higher in diabetic smokers than would be expected by adding the odds of smokers and diabetics, suggesting that when these presses intersect, their effect is multiplicative, not additive.

Discussion
==========

The association between type 2 diabetes and the subgingival microbiome has previously been studied using cultivation-based or targeted molecular approaches ([@bib71]; [@bib35]; [@bib21]). These investigations concluded that hyperglycemia does not influence the subgingival microbiome ([@bib66]). However, when we examined this ecosystem by combining a rigorous case-control clinical study design with a comprehensive microbiomics approach for community characterization, we found evidence to support the hypothesis that specific environmental presses influence both community structure and membership in the subgingival ecosystem in distinctive ways.

In the present investigation, the biggest differences in both smokers and diabetics were between healthy and diseased subjects, not between healthy and diseased sites in the same individual. Although early investigations suggested that shallow sites might be more closely aligned to health rather than with disease ([@bib40]), recent investigations using deep sequencing methodology suggest that periodontitis may result from a whole-mouth dysbiosis rather than site-specific changes ([@bib1]). The data presented here thus corroborate newly emerging evidence.

Periodontitis is a chronic disease, and the immuno-inflammatory effects of a dysbiotic microbiome take several years to manifest as clinically measurable disease. Therefore, it is challenging to establish cause and effect using a traditional prospective study design. In an effort to overcome this, we have used a case-control study design with both environmental drivers (diabetes and smoking) as well as periodontal health status (periodontal health and periodontitis) as variables. However, the oral cavity is an open microbial ecosystem with allochthonous and autochthonous members, and one of the greatest limitations of a cross sectional study design is the inability to distinguish between these two constituents. We have used two complementary strategies to surmount this issue. We defined the core microbiome of each group as the suite of species identified in ⩾80% of subjects and compared groups based on species that have been selected for by environmental drivers; a strategy that allows for comparisons of stable associations between groups. This approach was first delineated by the Human Microbiome Project ([@bib36]) and is now widely used in ecological investigations ([@bib4]; [@bib62]; [@bib15]). Diabetic smokers, however, demonstrated extreme microbial heterogeneity, with only 4% of the microbial suite common to the majority of the cohort. Hence, as a second strategy, we used network analysis of co-occurrence patterns to identify species that are niche-partners in each environment; drawing on similar methods used in other ecosystems ([@bib5]; [@bib24]).

An interesting finding was that, in contrast to the sparse congeneric clusters seen in normoglycemics and smokers with periodontitis, both diabetic nonsmokers and smokers demonstrated dense hubs made up of both congeneric and inter-generic networks. Congeneric species have a smaller evolutionary divergence and therefore, share similar morphological and ecological characteristics ([@bib61]). Hence, congeneric clusters are the norm in most niches. Inter-generic clusters, on the other hand, may be driven by two factors: (i) the inherent characteristics of the microenvironment to support organisms with similar lifestyle requirements (namely, oxygen tension, pH, redox potential and nutrient supply) and (ii) metabolic, structural and nutritional interbacterial partnerships. Taken together with the finding that diabetics demonstrated significant microbial heterogeneity, the data suggest that the hyperglycemic microenvironment enforces habitat filtering, favoring organisms that thrive under glucose-rich, pro-oxidant, protein-rich and anaerobic conditions.

This hypothesis finds further support in the significantly elevated levels of *Capnocytophaga, Pseudomonas, Bergeyella, Sphingomonas, Corynebacterium, Propionibacterium,* and *Neisseria* in hyperglycemic individuals. *Capnocytophaga* have been previously identified in high numbers in periodontitis in diabetics ([@bib13]), and these individuals demonstrate depressed IgG antibody profiles to these species ([@bib20]). *Capnocytophaga* also exhibit profuse growth in the presence of glucose ([@bib65]). *Pseudomonads* have been implicated in the etiology of diabetic foot infections ([@bib55]) and otitis media ([@bib70]); and glycemic levels are a critical determinant of bacterial burden in such infections ([@bib27]). Similar lines of evidence implicate *Corynebacterium, Propionibacterium* and *Sphingomonas* as causative organisms in polymicrobial skin and mucosal infections in diabetics ([@bib60]). *Neisseria* are well known for iron-piracy ([@bib57]); they extract it directly from human transferrin, an iron transport protein that is pathologically elevated in diabetics ([@bib52]). *Pseudomonas, Neisseria* and *Propionibacterium* are well-known stimulators of matrix metallo-proteinases (MMPs) ([@bib44]; [@bib53]; [@bib43]), an enzyme that plays a critical role in periodontal destruction. An important finding was that this shift in community membership and structure was evident even in the absence of clinical inflammation and periodontal destruction in diabetics, suggesting that these species may play a role in increasing susceptibility to periodontitis in these individuals.

Periodontitis is a significant public health concern, not only because the costs of treating this disease and its sequelae are comparable to outpatient treatment of cardiac and metabolic diseases ([@bib28]; [@bib23]; [@bib54]), but also because of its role in the pathogenesis of several life-threatening diseases, including cerebrovascular accidents and atherosclerosis ([@bib18]; [@bib16]). Hence, risk assessment is a critical element in disease prevention and successful therapeutic intervention. Our findings that smoking and diabetes affect the microbiome in distinct ways and that the synergistic impact of these two factors varies significantly from either in isolation underscores the need for developing a personalized risk assessment strategy that assigns differential weightage to each risk factor. It also underscores the importance of integrating microbial community-level metrics into periodontal risk assessments, rather than targeting individual species.
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![Similarity in microbial community configuration between deep and shallow sites. (**a**--**d**) show the principal coordinate analysis (PCoA) of UniFrac distances between deep and shallow sites in normoglycemic nonsmokers, normoglycemic smokers, hyperglycemic nonsmokers and hyperglycemic smokers. (**e**--**h**) show the kernel density plots of alpha diversity (ACE) between the same sites in the same individuals. The peak indicates the median values for each group, and the *x* axis shows the data range. Neither the PCoA nor the ACE values differed significantly between deep and shallow sites.](ismej201773f1){#fig1}

![Differences in alpha and beta diversity metrics between the four groups. Linear discriminant analysis (LDA) of relative abundances of species-level operational taxonomic units (s-OTUs) in normoglycemic nonsmokers, normoglycemic smokers, hyperglycemic nonsmokers and hyperglycemic smokers with periodontitis is shown in (**a**) (*P*=0.008, MANOVA Wilks test). LDA of diabetics clustered by glycemic control is shown in (**b**) (*P*=0.001). Density curves of alpha diversity (ACE) are shown in (**c**) (The peak indicates the median values for each group, and the *x* axis shows the data range) and distribution of s-OTUs by gram staining characteristics and oxygen requirements in (**d**). Groups that share the same symbol are significantly different from each other (*P*\<0.05, Kruskal--Wallis test).](ismej201773f2){#fig2}

![Core microbiome of normoglycemic nonsmokers, normoglycemic smokers, hyperglycemic nonsmokers and hyperglycemic smokers. (**a**) s-OTUs that were identified in the core microbiome of the four groups with periodontitis. (**b**) core microbiomes of periodontally healthy normoglycemics, periodontally healthy hyperglycemics and hyperglycemics with periodontitis. (**c**) core microbiomes of periodontally healthy nonsmokers, periodontally healthy smokers and smokers with periodontitis.](ismej201773f3){#fig3}

![Species that were uniquely identified in normoglycemic nonsmokers, normoglycemic smokers, hyperglycemic nonsmokers and hyperglycemic smokers with periodontitis, as well as those that were significantly different between groups (*P*\<0.05, FDR-adjusted Wald Test, DE-Seq2). Species are arranged by phylogeny and the fold differences (log2 scale) are shown.](ismej201773f4){#fig4}

![Co-occurrence networks in each group. Normoglycemic nonsmokers are shown in (**a**), hyperglycemic nonsmokers in (**b**), normoglycemic smokers in (**c**) and hyperglycemic smokers in (**d**). Each network graph contains nodes (circles sized by relative abundance per group) and edges (lines). Nodes represent species-level OTU\'s and edges represent Spearman's ρ. Edges are colored green for positive correlation and red for negative correlation. Only significant correlations (*P*\<0.05, *t*-test) with a coefficient of at least 0.75 are shown. Network anchors are highlighted in red font.](ismej201773f5){#fig5}

![Ecological shifts from health to disease in hyperglycemics. (**a**) shows the LDA plot of periodontally healthy normoglycemics, periodontally healthy hyperglycemics and hyperglycemic individuals with periodontitis (*P*=0.01, Manova Wilks test). Kernel density curves of alpha diversity (ACE) are shown in (**b**) (The peak indicates the median values for each group, and the *x* axis shows the data range) and distribution of s-OTUs by gram staining characteristics and oxygen requirements in (**c**). Groups that share the same symbol are significantly different from each other (*P*\<0.05, Kruskal--Wallis test).](ismej201773f6){#fig6}

![Ecological shifts from health to disease in smokers. (**a**) shows the LDA plot of periodontally healthy nonsmokers, periodontally healthy smokers and smokers with periodontitis (*P*=0.008, Manova Wilks test). Kernel density curves of alpha diversity (ACE) are shown in (**b**) (The peak indicates the median values for each group, and the *x* axis shows the data range) and distribution of s-OTUs by gram staining characteristics and oxygen requirements in (**c**). Groups that share the same symbol are significantly different from each other (*P*\<0.05, Kruskal--Wallis test).](ismej201773f7){#fig7}

###### Clinical and demongraphic features of subjects

  *Subjects with periodontitis*             *Subjects without periodontitis*                                                                                                          
  ---------------------------------------- ---------------------------------- ------------ ----------- ----------- ----------- ----------- ----------- ---------- --------- --------- ----------
  Age                                                    58±2.3                  58±6.6      50±9.8      56±6.3      40±9.8     49.2±3.8    41.3±6.3                                  
  HbA1c levels                                         4.75±0.36               6.72±0.78    4.7±0.39    7.73±2.1    4.2±0.13    6.78±0.91   4.3±0.32                                  
  Gender (% male)                                         65%                     73%          69%         78%         72%         75%         64%                                    
  BMI (normal weight: overweight: obese)                82:18:0                 79:21:0      87:13:0     74:26:0     85:15:0     78:22:0     85:15:0                                  
  Tobacco exposure (pack years)                            0                       0        15.3±1.9    12.1±2.9        0           0       11.7±1.3                                  
                                                          Deep                  Shallow       Deep       Shallow      Deep       Shallow      Deep      Shallow                            
  Mean PD (mm)                                          6.0±1.5                1.99 ±0.35   5.62±0.16   2.17±0.25   5.67±0.17   2.4±0.19    5.82±0.46   1.9±0.35   2.5±0.3   2.8±1.1   3.1±0.3
  Mean CAL (mm)                                         6.7±2.9                 1.1±0.9     4.75±0.34   1.75±0.27   4.75±0.5    1.02±0.3    5.32±0.44   0.73±0.3   0.8±0.2   1.2±0.1   0.9±0.19
  BOP (% sites)                                           100                   6.0±3.0        100       6.0±2.0       100       4.0±3.0       100      5.0±2.0    5.0±1.0   2.0±3.0   3.0±4.0

Abbreviation: BOP, bleeding on probing; BMI, body mass index; CAL, clinical attachment loss; PD, probe depth. Demographic, biometric and clinical periodontal characteristics of subjects.
